ANAB · Anaptysbio, Inc · Documents
$48.73
+0.63 (+1.31%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$1.42B
Shares
29.10M
Volume · Oct 23
468.21K
Avg daily vol (3M)
503.05K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2021-12-01 | — | |
| 8-K | — | 2021-11-29 | 2021-11-26 | |
| 8-K | — | 2021-11-15 | — | |
| 8-K | — | 2021-11-04 | — | |
| 10-Q | — | 2021-11-04 | 2021-09-30 | |
| 8-K | — | 2021-10-25 | — | |
| 8-K | — | 2021-10-04 | — | |
| 8-K | — | 2021-08-09 | — | |
| 10-Q | — | 2021-08-09 | 2021-06-30 | |
| 8-K | — | 2021-06-17 | — | |
| 8-K | — | 2021-06-03 | — | |
| 10-Q | — | 2021-05-04 | 2021-03-31 | |
| 8-K | — | 2021-05-04 | — | |
| DEF 14A | — | 2021-04-26 | 2021-06-17 | |
| DEFA14A | — | 2021-04-26 | — | |
| 8-K | — | 2021-04-12 | 2021-04-08 | |
| 8-K | — | 2021-03-08 | — | |
| 8-K | — | 2021-02-25 | — | |
| 10-K | — | 2021-02-25 | 2020-12-31 | |
| 8-K | — | 2021-01-19 | 2021-01-18 | |
| 8-K | — | 2021-01-11 | — | |
| 8-K | — | 2020-11-17 | 2020-11-11 | |
| 8-K | — | 2020-11-04 | — | |
| 10-Q | — | 2020-11-04 | 2020-09-30 | |
| 8-K | — | 2020-10-26 | 2020-10-23 | |
| 8-K | — | 2020-10-13 | — | |
| 8-K | — | 2020-08-20 | — | |
| 8-K | — | 2020-08-10 | — | |
| 10-Q | — | 2020-08-10 | 2020-06-30 | |
| 8-K | — | 2020-07-31 | 2020-07-20 | |
| 8-K | — | 2020-07-15 | 2020-07-13 | |
| 8-K | — | 2020-06-19 | — | |
| 10-Q | — | 2020-05-06 | 2020-03-31 | |
| 8-K | — | 2020-05-06 | — | |
| DEF 14A | — | 2020-04-27 | 2020-06-19 | |
| DEFA14A | — | 2020-04-27 | — | |
| 8-K | — | 2020-03-09 | 2020-03-06 | |
| 10-K | — | 2020-03-02 | 2019-12-31 | |
| 8-K | — | 2020-03-02 | — | |
| 8-K | — | 2020-01-15 | — |
Showing 101–140 of 140 filings
Key facts
CIK
1370053
CUSIP
032724106
13F (30d)
19 filings
19 filers
Visit website
Investor relations